Karina Cordero-Torres

Prof. Dr. Karina Cordero-Torres

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2023 in Oral Diseases
Verified
Journal Article
Closed access
GGGerardo Gilligan
Gerardo Gilligan
RPRené Panico
René Panico
JLJerónimo Lazos
Jerónimo Lazos
RMRosana Andrea Morelatto
Rosana Andrea Morelatto
PBPaola Belardinelli
Paola Belardinelli
EPEduardo David Piemonte
Eduardo David Piemonte

1 May 2010 in Oncology Letters
Verified
Journal Article
Open access
PDF file
Karina Cordero-TorresKarina Cordero-Torres
Karina Cordero-Torres
IEIris Espinoza
Iris Espinoza
DCDante Caceres
Dante Caceres
ARAngela Roco
Angela Roco
CMCarla Miranda
Carla Miranda
Luis A. QuiñonesLuis A. Quiñones
Luis A. Quiñones
Polycyclic aromatic hydrocarbons (PAHs) contained in tobacco smoke acquire carcinogenicity following their activation by xenobiotic-metabolizing enzymes to highly reactive metabolites. The cytochrome P4501A1 (CYP1A1) enzyme is central to the metabolic activation of these PAHs, and GSTM1 is the main enzyme responsible for its detoxification. CYP1A1 and GSTM1 polymorphisms were evaluated in 124 Chilean healthy controls and 48 oral cancer patients through PCR-based restriction fragment length polymorphism. In the healthy controls, frequencies of the CYP1A1 variant alleles for m1 (CYP1A1*2A) and the GSTM1null genotype were found to be 0.25 and 0.19, respectively. In the oral cancer patients, these frequencies were 0.33 and 0.50, respectively. Thus, the GSTM1 and m1 rare alleles were significantly more frequent in the oral cancer patients compared to the controls. The estimated relative risk for oral cancer associated with the single genotype CYP1A1 or GSTM1 was 2.08 for wt/m1, 1.04 for m1/m1 and 4.16 for the GSTM1null genotype. For smokers, the estimated relative risk (adjusted by age and gender) was higher in the individuals carrying the m1 allele of CYP1A1 [wt/m1: odds ratio (OR)=5.68, P=0.0080; m1/m1: OR=7.77, P=0.0420] or GSTM1null genotype (OR=20.81, P<0.0001). Combined genotypes CYP1A1 and GSTM1 increased the risk significantly (wt/m1/GSTM1null: OR=19.14, P=0.0030; m1/m1/GSTM1null: OR=21.39, P=0.0130). Taken together, these findings suggest that Chilean individuals carrying single or combined GSTM1 and CYP1A1 polymorphisms may be more susceptible to oral cancer induced by environmental tobacco smoking.

29 January 2012 in Journal of Transplantation
Verified
Journal Article
Open access
PDF file
GRGonzalo Rojas
Gonzalo Rojas
LBLoreto Bravo
Loreto Bravo
Karina Cordero-TorresKarina Cordero-Torres
Karina Cordero-Torres
LSLuis Sepúlveda
Luis Sepúlveda
LELeticia Elgueta
Leticia Elgueta
IMIrene Morales
Irene Morales
The relationship between the use of immunosuppressants in solid-organ transplant patients and oral tissue abnormalities has been recognized. The objective of this study was to determine the state of oral tissue integrity in renal, heart, and liver transplant patients who are on continuous medical and dental control. Forty patients of both sexes were clinically evaluated at the Clinical Hospital of the University of Chile to identify pathologies of oral mucosa, gingival enlargement (GE), decayed, missing, filled teeth (DMFT) index, and salivary flow. The average age of the transplant subjects was 49.4 years, and the age range was 19 to 69 years. Most subjects maintained a good level of oral hygiene, and the rate mean of DMFT was 14.7. The degree of involvement of the oral mucosa and GE was low (10%). Unlike other studies, the frequency of oral mucosal diseases and GE was low despite the fact that these patients were immunosuppressed. Care and continuous monitoring seem to be of vital importance in maintaining the oral health of transplant patients.

1 February 2022 in Journal of Oral and Maxillofacial Pathology
Verified
Journal Article
Open access
PDF file
IMIgnacio Molina-Ávila
Ignacio Molina-Ávila
ARAndrea Arellano Rojas
Andrea Arellano Rojas
GGGerardo Gilligan
Gerardo Gilligan
Karina Cordero-TorresKarina Cordero-Torres
Karina Cordero-Torres
Chewing coca leaves is a habit still practiced in Bolivia, Peru and Argentina. There is scarce evidence in the relationship between this habit and development of oral squamous cell carcinoma (OSCC), some authors have found oral epithelial changes in coca chewers. This study aimed to present a case series of patients with a coca chewing habit that developed OSCC, in the absence of risk factors for oral cancer. Patients were evaluated in Hospital Señor del Milagro, Salta, Argentina. None of them had a relevant morbid history and presented intraoral tumors, with an ulcerated surface on the gingivobuccal complex. Coca chewing habit was recorded in all cases. Present cases could start discussions and new lines of researches focusing on the habit of coca leaves chewing as a risk factor for OSCC. It would be very useful to know the underlying mechanisms between this habit and a possible role in oral carcinogenesis.

25 March 2026 in JMIR AI
Verified
Journal Article
Open access
Jaime Eduardo Jamett RojasJaime Eduardo Jamett Rojas
Jaime Eduardo Jamett Rojas
PRPatricio Melendez Rojas
Patricio Melendez Rojas
Ximena Collao-FerradaXimena Collao-Ferrada
Ximena Collao-Ferrada
Karina Cordero-TorresKarina Cordero-Torres
Karina Cordero-Torres
AVAlejandro Veloz
Alejandro Veloz
Background: Fuzzy logic has been progressively investigated as a viable alternative to traditional statistical and machine learning methods in health care modeling, especially in environments marked by uncertainty, nonlinearity, and missing information. Although its use in prediction, classification, and risk stratification is well established, its application to explicit causal inference remains limited, varied, and methodologically premature. Objective: This systematic review aimed to examine how fuzzy logic frameworks have been used to address causal questions in health care, focusing on their methodological characteristics, comparative performance, and degree of integration with formal causal inference approaches. Methods: A systematic search across 6 databases (PubMed, Web of Science, ScienceDirect, SpringerLink, Scopus, and IEEE Xplore) identified peer-reviewed studies published between 2014 and 2025 that applied fuzzy modeling in health care settings with explicit or implicit causal objectives. The review adhered to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines and used a modified PICO (population, intervention, comparator, and outcome) framework for study selection. Data were extracted on the health care domain, fuzzy method, comparator use, and causal framing. Risk of bias was evaluated using the Joanna Briggs Institute (JBI) checklist and the PROBAST+AI tool, according to study design. Results: A total of 37 studies met the inclusion criteria. The most frequently applied approaches were fuzzy inference systems, fuzzy cognitive maps, and neuro-fuzzy models, with applications spanning infectious diseases, cancer, cardiovascular health, mental health, and occupational health. Fourteen studies included comparator models; among these, 5 reported superior performance of fuzzy approaches, 3 showed comparable results, and 6 lacked sufficient detail for a robust comparison. Only 2 studies explicitly implemented formal causal inference frameworks, while most relied on predictive or associative modeling with implicit causal assumptions. Overall, the risk of bias was moderate to high. Conclusions: Fuzzy logic offers interpretability and flexibility well suited to complex health care problems, yet its application to explicit causal inference remains fragmented. Greater methodological transparency, systematic benchmarking, and integration with formal causal designs—such as counterfactual and target trial frameworks—are required to establish fuzzy logic as a robust paradigm for causal inference in health care.

21 May 2020 in Revista Facultad de Odontología
Verified
Journal Article
Open access
PDF file
IÁIgnacio Molina Ávila
Ignacio Molina Ávila
MVMercedes Villalobos
Mercedes Villalobos
MCMaría Laura Caporaletti
María Laura Caporaletti
Karina Cordero-TorresKarina Cordero-Torres
Karina Cordero-Torres
Introducción: muchos pacientes que viven con VIH-SIDA (PVVS) se sienten discriminados por su enfermedad, tanto en el ámbito social como en establecimientos de salud, incluyendo la atención odontológica. Sin embargo, en la actualidad no existen en Argentina estudios que permitan establecer las preferencias de estos pacientes al momento de acudir a un odontólogo, como el lugar donde prefieren ser atendidos, o si mencionan su condición de VIH(+), entre otros aspectos. Objetivo: determinar la apreciación de las PVVS sobre la atención odontológica en Salta, Argentina. Métodos: estudio descriptivo, de corte transversal. La población estudiada fueron sujetos que acudieron al Programa Provincial VIH/ITS de Salta entre junio y septiembre de 2015. Se recolectaron datos sociodemográficos, enfermedad de base y atención odontológica, en una encuesta diseñada para tal fin. Resultados: se encuestaron 200 PVVS: 54% de género masculino, con una edad promedio de 37 años (RIC 29,2-45), tiempo mediano de evolución de la enfermedad de 78 meses (RIC 30-126). Un 78% consultó al odontólogo en los últimos dos años y 60% utilizó establecimientos públicos como lugar de atención. Un 70% percibió que el odontólogo tiene conocimientos sobre VIH. El 50,5% manifestó su estado serológico al profesional tratante. 87% refirió que recibieron atención odontológica sin ningún prejuicio. Del 49,6% que no dio a conocer su diagnóstico, el 55% adujo miedo a la discriminación. Conclusión: si bien la apreciación de las PVVS sobre la atención odontológica fue positiva, mayoritariamente sin prejuicios, el miedo a la discriminación es la principal causa para no dar a conocer el diagnóstico al odontólogo. El trabajo interdisciplinario ayudaría a las PVVS en la atención integral, evitando ser un motivo más para la falta de adherencia al tratamiento.